f5f1d056-97da-4bad-9703-84ffd993d073.pdf

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

GRANT OF SHARE OPTIONS BY HUTCHISON CHINA MEDITECH LIMITED

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

The board of directors (the "Board") of CK Hutchison Holdings Limited (the "Company") announces that on 15 June 2016, 693,686 share options were granted by Hutchison China MediTech Limited ("HCML", an approximately 60.46% held subsidiary of the Company, whose shares are traded on the AIM market of the London Stock Exchange and in the form of American Depositary Shares on the NASDAQ Stock Market) under its share option scheme (the "HCML Scheme", which was unconditionally adopted on 13 May 2016) to certain Eligible Employees (as defined in the HCML Scheme) to subscribe for ordinary shares of nominal value of US$1 each of HCML (each a "HCML Share"). Details of such share options are as follows:

Date of grant

:

15 June 2016

Exercise price of share options granted

:

GBP19.70 per HCML Share

Number of share options granted

:

693,686 (each share option shall entitle the holder thereof to subscribe for one HCML Share)

Closing market price of the HCML Shares on the date of grant

:

GBP19.70 per HCML Share

Validity period of the share options

:

from 15 June 2016 to 19 December 2023,

save for 100,000 options from 15 June 2016 to 27 June 2024 (subject to vesting conditions)

The grantees are neither a director, chief executive nor substantial shareholder of HCML, or an associate (as defined under the Listing Rules) of any of them.

By Order of the Board

Edith Shih

Company Secretary

Hong Kong, 20 June 2016

As at the date of this announcement, the Directors of the Company are:

Executive Directors

Mr LI Ka-shing (Chairman)

Mr LI Tzar Kuoi, Victor (Group Co-Managing Director and Deputy Chairman)

Mr FOK Kin Ning, Canning

(Group Co-Managing Director)

Mrs CHOW WOO Mo Fong, Susan

(Group Deputy Managing Director)

Mr Frank John SIXT (Group Finance Director and Deputy Managing Director)

Mr IP Tak Chuen, Edmond

(Deputy Managing Director)

Mr KAM Hing Lam

(Deputy Managing Director)

Mr LAI Kai Ming, Dominic

(Deputy Managing Director)

Non-executive Directors:

Mr CHOW Kun Chee, Roland Mr LEE Yeh Kwong, Charles Mr LEUNG Siu Hon

Mr George Colin MAGNUS

Independent Non-executive Directors:

Mr KWOK Tun-li, Stanley

Mr CHENG Hoi Chuen, Vincent

The Hon Sir Michael David KADOORIE Ms LEE Wai Mun, Rose

Mr William Elkin MOCATTA (Alternate to The Hon Sir Michael David Kadoorie)

Mr William SHURNIAK Mr WONG Chung Hin

Dr WONG Yick-ming, Rosanna

CK Hutchison Holdings Limited published this content on 20 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 June 2016 05:45:02 UTC.

Original documenthttp://www.irasia.com/listco/hk/ckh/announcement/a160792-e_announcement.pdf

Public permalinkhttp://www.publicnow.com/view/A6EAD95FED2F473F71BE16F9F5C81E204846D1BF